BM

Bill & Melinda Gates Foundation

13F
Bill & Melinda Gates Foundation
Last update 2024-08-14 6 Stocks (0 new)
Value $60.00 Mil Turnover 0 %
Countries:
Top Holdings: IMCR(32.71%)VIR(23.22%)BNTX(19.99%)EXAI(13.57%)CVAC(9.09%)
Portfolio Report
Summary Stock Picks Current Portfolio
Bill & Melinda Gates Foundatio... Top Holdings of 2024-06-30 View Full List
Ticker
Company
Shares
Value ($1000)
Shares Change %
Weighting %
Trade Impact %
% of Shares outstanding
3M Change %
YTD Change %
Market Cap $Mil
Industry
IMCR 		Immunocore Holdings PLC
576,923
19551.920
0%
32.710
0%
1.150
-11.01%
-51.71%
1650.119
Biotechnology
VIR 		Vir Biotechnology Inc
1,559,142
13876.360
0%
23.220
0%
1.140
+11.45%
-4.17%
1327.622
Biotechnology
BNTX 		BioNTech SE
148,674
11947.440
0%
19.990
0%
0.060
+41.62%
+5.14%
26603.948
Biotechnology
EXAI 		Exscientia PLC
1,590,909
8113.640
0%
13.570
0%
1.260
+21.36%
-19.34%
676.339
Biotechnology
CVAC 		CureVac NV
1,597,637
5431.970
0%
9.090
0%
0.710
-7.57%
-30.40%
657.240
Biotechnology
BFLY 		Butterfly Network Inc
1,011,003
849.240
0%
1.420
0%
0.480
+142.57%
+126.85%
522.002
Medical Devices & Instruments
BCEL 		Atreca Inc
0
0.000
Sold Out
0.000
-0.09%
0.000
-54.77%
-31.82%
3.569
Biotechnology
LMDXF 		LumiraDx Ltd
0
0.000
Sold Out
0.000
-0.17%
0.000
+1,900.00%
-84.10%
3.191
Medical Diagnostics & Research

Bill & Melinda Gates Foundation's Historical Top Holdings Breakdowns

Bill & Melinda Gates Foundation's Top Stock Picks View Full List
Ticker
Company
Date
Action
Impact %
Price Range
Price
Price Change from Avrg%
Comment
Current Shares
Share Change
LMDXF 		LumiraDx Ltd2024-06-30Sold Out
-0.17%
●
0.01 ($0.02) 0.03
$0.01
-50.00%
Sold Out
0
-14,285,714
BCEL 		Atreca Inc2024-06-30Sold Out
-0.09%
●
0.07 ($0.09) 0.1
$0.09
0%
Sold Out
0
-912,642
CVAC 		CureVac NV2024-03-31Reduce
-0.13%
●
2.94 ($3.51) 4.34
$2.93
-16.52%
Reduce -1.74%
1,597,637
-28,306
AMRSQ 		Amyris Inc2023-12-31Sold Out
-0.02%
●
0 ($0.01) 0.06
$0
-80.00%
Sold Out
0
-292,398
BCEL 		Atreca Inc2023-09-30Reduce
-0.02%
●
0.26 ($0.63) 1.12
$0.09
-85.71%
Reduce -2.06%
912,642
-19,173
BCEL 		Atreca Inc2023-06-30Reduce
-0.08%
●
0.88 ($1.03) 1.22
$0.09
-91.26%
Reduce -7.43%
931,815
-74,764
BCEL 		Atreca Inc2023-03-31Reduce
-0.12%
●
0.91 ($1.45) 1.82
$0.09
-93.79%
Reduce -16.54%
1,006,579
-199,518
CVAC 		CureVac NV2022-12-31Reduce
-0.52%
●
5.75 ($7.39) 8.5
$2.93
-60.35%
Reduce -4.9%
1,625,943
-83,838
ZY Zymergen Inc2022-12-31Sold Out
-0.16%
●
2.35 ($2.65) 3.14
$2.43
-8.30%
Sold Out
0
-59,970
BCEL 		Atreca Inc2022-12-31Reduce
-0.14%
●
0.78 ($1.27) 1.83
$0.09
-92.91%
Reduce -8.69%
1,206,097
-114,783

Bill & Melinda Gates Foundation Total Holding History ($B)

To

Bill & Melinda Gates Foundation's Asset Allocation

To

Bill & Melinda Gates Foundation Past Portfolios

Portfolio Date Number of Stocks New Stocks Total Value ($Mil) Q/Q Turnover

Top Ranked Articles

  • 1

Bill & Melinda Gates Foundation's Hypothetical Growth since 2024-06-30

Bill & Melinda Gates Foundation's Yearly Returns

Year Portfolio % % Excess Gain %

Bill & Melinda Gates Foundation's Holdings Heat Map

Size field:

Bill & Melinda Gates Foundation's Holdings Bubble Chart

Bill & Melinda Gates Foundation News

  • 1

Discussions on Bill & Melinda Gates Foundation

No discussions yet.
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2024 GuruFocus.com, LLC. All Rights Reserved.